This is a non-core endpoint: only basic statistics are computed.
See its core counterpart C3_ALL_EXALLC for full statistics.
Acute lymphocytic leukaemia
C3_ALL
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditions
|
237 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
237 |
4. Check minimum number of eventsNone |
237 |
5. Include endpoints |
237 |
6. Filter based on genotype QC (FinnGen only) |
237 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- C
- First used in FinnGen datafreeze
- DF8
Similar endpoints
↥List of similar endpoints to
Acute lymphocytic leukaemia
based on the number of shared cases.
Similar with more cases:
- Acute lymphocytic leukaemia, helper endpoint
- Acute lymphocytic leukaemia, excluding all cancers (controls excluding all cancers)
- Any event in cancer register
- Any event in hilmo or specialist outpatient
- Any prescribed medicine buy
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 237 | 132 | 105 |
| Unadjusted period prevalence (%) | 0.05 | 0.04 | 0.05 |
| Median age at first event (years) | 9.23 | 6.99 | 12.05 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 237
- Matched controls
- 2371
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
3260.0
291.8
229
20
C91.0
ICD-10 Finland
Acute lymphoblastic leukaemia [ALL]
13656.8
266.5
204
*
9835/3-C42.1
ICD-O-3
Precursor cell lymphoblastic leukemia, NOS, of bone marrow
+∞
237.2
186
*
L01BB02
ATC
mercaptopurine; oral
304.4
161.4
149
13
TAB00
NOMESCO Finland
Lumbar puncture
62.8
119.3
139
52
H02AB02
ATC
dexamethasone; systemic
45.0
101.8
128
60
H02AB09
ATC
hydrocortisone; systemic
51.1
92.2
111
40
XW000
NOMESCO Finland
Bone marrow biopsy
61.6
91.1
105
30
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
65.2
89.5
102
27
Z85.6
ICD-10 Finland
Personal history of leukaemia
1042.7
79.1
73
*
L04AX03
ATC
methotrexate; systemic (immunosuppressants)
20.8
66.2
105
87
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
62.6
62.0
71
16
NEA10
NOMESCO Finland
Exploration of soft tissue of pelvis, percutaneous
231.7
54.5
54
*
2040A
ICD-9 Finland
Lymphoid leukaemia, Acute
609.6
51.5
49
*
L03AA02
ATC
filgrastim; parenteral
46.1
51.1
62
18
9811/3-C42.1
ICD-O-3
B lymphoblastic leukemia/lymphoma, NOS, of bone marrow
+∞
50.9
47
*
C91.1
ICD-10 Finland
Chronic lymphocytic leukaemia of B-cell type
+∞
45.3
42
*
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
26.4
44.9
63
32
ZX131
NOMESCO Finland
Intrathecal
+∞
41.9
39
*
TPX10
NOMESCO Finland
Implantation of vascular injection port
27.8
40.7
56
26
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
14.0
38.8
70
69
A04AA01
ATC
ondansetron; systemic, rectal
12.6
33.6
63
66
A41.9
ICD-10 Finland
Sepsis, unspecified
20.1
32.9
50
31
R50.9
ICD-10 Finland
Fever, unspecified
6.5
32.8
103
250
127
Kela drug reimbursment
Transplant complication
35.1
32.0
41
14
H02AB06
ATC
prednisolone; systemic
5.1
30.7
148
581
L01BA01
ATC
methotrexate; systemic (folic acid analog.)
17.9
30.4
48
33
J05AB11
ATC
valaciclovir; oral
8.0
30.1
75
129
Z03.5
ICD-10 Finland
Observation for other suspected cardiovascular diseases
9.4
29.9
66
93
WW500
NOMESCO Finland
Blood transfusion
15.2
29.5
50
41
Z94.8
ICD-10 Finland
Other transplanted organ and tissue status
118.3
29.4
31
*
C95.0
ICD-10 Finland
Acute leukaemia of unspecified cell type
118.3
29.4
31
*
20400
ICD-8 Finland
Lymphatic leukaemia, Acute
+∞
28.7
27
*
C92.0
ICD-10 Finland
Acute myeloblastic leukaemia [AML]
316.9
28.4
28
*
9101
FHL
Bone biopsy
+∞
27.6
26
*
A05AA02
ATC
ursodeoxycholic acid; oral
29.0
27.6
37
15
J02AC01
ATC
fluconazole; systemic
4.7
26.8
128
475
1XX02
NOMESCO Finland
NA
+∞
26.6
25
*
ZX114
NOMESCO Finland
Intramuscular
29.1
26.2
35
14
K03.66
ICD-10 Finland
Tooth plaque
6.6
24.8
71
145
ZXE00
NOMESCO Finland
One hour or less
4.0
22.4
145
673
C91.9
ICD-10 Finland
Lymphoid leukaemia, unspecified
241.4
22.0
22
*
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
5.7
21.5
68
155
ZXD00
NOMESCO Finland
Emergency procedure
18.0
21.3
33
21
ZXD05
NOMESCO Finland
Urgent procedure
3.8
19.9
114
463
M04AA01
ATC
allopurinol; systemic
9.1
19.4
42
55
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
15.2
19.4
32
24
ZX121
NOMESCO Finland
Central venous catheter
37.9
19.3
24
7
WB123
NOMESCO Finland
Demanding adjuvant cytostatic therapy
27.7
18.6
25
10
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
4.4
18.4
77
233
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
14.8
18.0
30
23
2301
FHL
Lumbar puncture in anesthesia or operating room
+∞
17.9
17
*
A06AD11
ATC
lactulose; oral
6.1
17.9
52
105
121
Kela drug reimbursment
Severe hypofunction of sexual glands
20.7
17.8
26
14
T86.0
ICD-10 Finland
Bone-marrow transplant rejection
193.9
17.8
18
*
J05AB01
ATC
aciclovir; systemic
4.3
17.5
75
231
L03AA10
ATC
lenograstim; parenteral
+∞
16.9
16
*
ZX120
NOMESCO Finland
Intravenous
6.3
16.8
47
90
WX404
NOMESCO Finland
Intravenous generell anesthesy
3.6
16.3
91
346
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
4.0
16.1
74
241
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
4.1
15.7
69
215
D69.6
ICD-10 Finland
Thrombocytopenia, unspecified
20.0
15.0
22
12
D89.89
ICD-10 Finland
Other specified disorders involving the immune mechanism, not elsewhere classified
85.5
14.8
16
*
9109
FHL
Other measure in this category
+∞
14.7
14
*
L01BB03
ATC
tioguanine; oral
+∞
14.7
14
*
602
Kela drug reimbursment
Children's severe malnutrition
15.8
14.4
23
16
A01AB09
ATC
miconazole; local oral
5.8
14.3
42
85
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
14.8
14.1
23
17
XF400
NOMESCO Finland
ECG with 12 standard connections
3.8
13.8
66
219
GD1AA
NOMESCO Finland
Thorax X-ray examination
3.0
13.8
105
491
WD135
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
36.4
13.7
17
5
2AX04
NOMESCO Finland
NA
+∞
13.7
13
*
WW306
NOMESCO Finland
Transfer of stem cells from foreign registered donator
148.1
13.6
14
*
J01EE02
ATC
sulfadiazine and trimethoprim; systemic
2.9
13.4
115
581
ZXE10
NOMESCO Finland
More than one and less than three hours
3.0
13.3
106
509
Z3229
NOMESCO Finland
Other healthcare associate professional
5.2
13.3
43
97
J01MA12
ATC
levofloxacin; systemic
4.5
13.3
50
133
L04AA06
ATC
mycophenolic acid; systemic
16.7
12.9
20
13
ZXA00
NOMESCO Finland
Right side
3.5
12.8
69
251
J02AC03
ATC
voriconazole; systemic
+∞
12.6
12
*
0388X
ICD-9 Finland
Septicaemia, Other specified septicaemias
+∞
12.6
12
*
A02BC01
ATC
omeprazole; systemic
3.3
12.6
74
285
D32.00
ICD-10 Finland
Benign tumor of the meninges on the outer surface of the cerebrum
39.8
12.4
15
*
G62.0
ICD-10 Finland
Drug-induced polyneuropathy
68.4
11.7
13
*
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
4.3
11.7
45
122
A04AA02
ATC
granisetron; systemic, transdermal
9.1
11.6
24
29
L01XE06
ATC
[U] dasatinib; systemic
+∞
11.5
11
*
Z92.6
ICD-10 Finland
Personal history of chemotherapy for neoplastic disease
+∞
11.5
11
*
C95.9
ICD-10 Finland
Leukaemia, unspecified
+∞
11.5
11
*
FM2CE
NOMESCO Finland
NA
7.1
11.5
28
44
R4110
NOMESCO Finland
Physiotherapy
3.0
11.5
81
353
A49.9
ICD-10 Finland
Bacterial infection, unspecified
5.5
11.4
34
70
D72.8
ICD-10 Finland
Other specified disorders of white blood cells
26.5
11.3
15
6
ZX090
NOMESCO Finland
Other technic of radiotherapy
14.9
11.2
18
13
D70.89
ICD-10 Finland
Neutropenic splenomegaly
12.8
11.1
19
16
L04AA01
ATC
[U] ciclosporin; systemic
13.8
10.8
18
14
Z2446
NOMESCO Finland
Social worker
3.6
10.7
51
166
A41.1
ICD-10 Finland
Sepsis due to other specified staphylococcus
62.9
10.7
12
*
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
7.4
10.7
25
37
Z3226
NOMESCO Finland
Physiotherapist
3.1
10.6
68
275
D64.9
ICD-10 Finland
Anaemia, unspecified
5.4
10.6
32
67
1CX01
NOMESCO Finland
NA
+∞
10.5
10
*
150
Kela drug reimbursment
Dasatinib
+∞
10.5
10
*
WW304
NOMESCO Finland
Transfer of stem cells from registered domestic donator
+∞
10.5
10
*
J02AC04
ATC
posaconazole; systemic
+∞
10.5
10
*
A01AB04
ATC
amphotericin B; local oral
11.4
10.5
19
18
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
6.7
10.3
26
43
ZX108
NOMESCO Finland
Inhalation
14.2
9.8
16
12
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
7.7
9.8
22
31
WW409
NOMESCO Finland
Other aferesis
57.4
9.7
11
*
K02.0
ICD-10 Finland
Caries limited to enamel
2.8
9.7
74
333
B73
ICPC
Leukaemia
104.0
9.5
10
*
WW302
NOMESCO Finland
Allogenic transfer of stem cells from relative
+∞
9.4
9
*
2AA01
NOMESCO Finland
NA
+∞
9.4
9
*
K00.40
ICD-10 Finland
Postnatal enamel hypoplasia
7.6
9.3
21
30
L04AD01
ATC
ciclosporin; systemic
8.2
8.8
19
25
Y84
ICD-10 Finland
Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
52.0
8.7
10
*
WX408
NOMESCO Finland
General anesthesy, balanced
2.5
8.6
81
406
Z2221
NOMESCO Finland
Medical doctor
2.4
8.4
86
450
G03BA03
ATC
testosterone; systemic, rectal, sublingual, transdermal
5.8
8.1
22
41
C90.0
ICD-10 Finland
Multiple myeloma
15.7
7.8
12
8
M87.1
ICD-10 Finland
Osteonecrosis due to drugs
46.5
7.8
9
*
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
6.6
7.7
19
31
AAB00
NOMESCO Finland
Extirpation of intracranial lesion
19.1
7.7
11
6
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
12.4
7.7
13
11
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
2.2
7.6
102
602
ZXM00
NOMESCO Finland
Intraoperative use of ultrasonographic imaging
82.6
7.5
8
*
Z08.2
ICD-10 Finland
Follow-up examination after chemotherapy for malignant neoplasm
82.6
7.5
8
*
WB133
NOMESCO Finland
Very demanding adjuvant cytostatic therapy
82.6
7.5
8
*
5639
FHL
Other measure in this category
82.6
7.5
8
*
N02AA05
ATC
oxycodone; systemic
3.7
7.3
32
97
M87.3
ICD-10 Finland
Other secondary osteonecrosis
+∞
7.3
7
*
5604
FHL
Vascular preparation or cannulation in the operating room
31.0
7.2
9
*
ZXA10
NOMESCO Finland
Bilateral
2.8
7.2
50
208
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.6
7.0
55
246
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
14.3
7.0
11
8
SBB20
NOMESCO Finland
Tooth X-ray examination in conjunction with visit to dentist
17.3
6.8
10
6
D32.02
ICD-10 Finland
Benign tumor of the meninges at the base of the brain
41.3
6.8
8
*
1AB02
NOMESCO Finland
NA
41.3
6.8
8
*
GD1LA
NOMESCO Finland
GD
23.3
6.7
9
*
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
12.7
6.6
11
9
504
Kela drug reimbursment
Conditions requiring daily forced enteral nutrition
9.1
6.6
13
15
A07AA02
ATC
nystatin; oral
4.7
6.5
21
48
ZXE06
NOMESCO Finland
Procedure duration 50 to 59 minutes
3.3
6.5
32
107
TDM10
NOMESCO Finland
Puncture of maxillary antrum
5.5
6.5
18
35
6BA02
NOMESCO Finland
NA
71.7
6.5
7
*
189
Kela drug reimbursment
Imatinib
71.7
6.5
7
*
TPW99
NOMESCO Finland
Other minor surgical procedure on peripheral vessel or lymphatic system
8.5
6.4
13
16
Z31.6
ICD-10 Finland
General counselling and advice on procreation
9.7
6.4
12
13
SAA03
NOMESCO Finland
Extended examination of mouth
2.0
6.4
131
902
IEP04
NOMESCO Finland
Focused parenting intervention
18.6
6.3
9
5
D32.01
ICD-10 Finland
Benign tumor of meninges on interhemispheric surface
+∞
6.3
6
*
B28
ICPC
Limited function/disability (B)
+∞
6.3
6
*
324
Kela drug reimbursment
Dasatinib
+∞
6.3
6
*
L01AA01
ATC
cyclophosphamide; systemic
+∞
6.3
6
*
C90.1
ICD-10 Finland
Plasma cell leukaemia
+∞
6.3
6
*
ZXA05
NOMESCO Finland
Left side
2.5
6.2
50
227
JN4BD
NOMESCO Finland
Extensive body CT
3.8
6.1
25
72
B02.9
ICD-10 Finland
Zoster without complication
4.8
6.1
19
42
ZXX02
NOMESCO Finland
Extent of procedure, 2 units
9.0
6.1
12
14
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
2.0
6.0
117
782
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.4
6.0
56
273
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(21494434) Karyotype in Bone marrow
38
19
23.63
50.50
1.3
1.4
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
53
55
12.12
47.50
12.8
2.0
—
—
—
0
0
(3032352) Blasts [#/volume] in Cerebral spinal fluid
49
5
122.91
46.81
8.3
2.8
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
36
21
20.03
44.57
1.8
2.0
—
—
—
0
0
(3011412) CD3 cells [#/volume] in Blood
39
29
15.90
42.68
7.6
2.4
e9/l
1.2
1.8
1.36
25
19
(3024932) HLA-DR beta [Type]
28
11
28.73
40.48
1.2
1.3
—
—
—
0
0
(3024471) HLA-A [Type]
28
11
28.73
40.48
1.0
1.0
—
—
—
0
0
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
50
60
10.29
40.14
13.3
1.9
e6/l
10.0
6.4
0.16
45
52
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
50
60
10.29
40.14
13.3
2.0
e6/l
29.1
86.7
0.84
45
54
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
37
28
15.47
40.02
6.4
2.3
%
6.6
9.7
1.12
27
21
(1175426) CD3 cells/100 lymphocytes in Blood
37
28
15.47
40.02
6.4
2.3
%
76.9
68.3
1.20
37
28
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
41
37
13.19
39.98
4.4
1.6
—
—
—
0
0
(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood
35
25
16.25
39.04
8.1
2.0
e9/l
0.1
0.2
1.05
27
19
(3008757) Leukocyte morphology finding [Identifier] in Blood
35
26
15.62
38.19
12.7
4.5
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
34
24
16.37
38.13
3.4
1.7
—
—
—
0
0
(3017115) Methotrexate [Moles/volume] in Serum or Plasma
40
5
95.35
37.12
23.8
30.4
umol/l
0.4
0.5
—
40
5
(3023323) Follitropin [Units/volume] in Serum or Plasma
65
118
7.21
36.58
2.9
2.0
iu/l
8.4
15.0
1.64
50
98
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
34
26
15.10
36.46
8.3
2.0
e6/l
663.8
545.4
0.40
26
19
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
42
45
11.13
36.46
5.0
1.7
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
74
155
6.49
36.11
7.3
2.1
g/l
7.7
9.8
4.86
74
148
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
42
46
10.88
35.88
4.4
1.6
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
38
36
12.38
35.81
15.8
2.3
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
34
27
14.53
35.67
3.3
1.7
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
32
23
15.93
35.47
9.5
2.9
—
—
—
0
0
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
39
40
11.47
34.84
17.2
8.2
iu/ml
326.2
457.2
—
10
5
(3009214) Lutropin [Units/volume] in Serum or Plasma
64
122
6.82
34.21
3.0
2.0
u/l
6.8
8.0
0.34
46
98
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
32
26
14.07
33.05
6.9
2.4
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
29
21
15.60
31.92
9.1
1.8
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
65
140
6.02
30.43
11.2
3.5
e9/l
56.7
69.1
1.93
50
107
(3030905) Polymorphonuclear cells [#/volume] in Blood
34
36
10.86
29.56
2.9
3.7
e9/l
3.2
3.7
0.59
34
36
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
34
36
10.86
29.56
3.9
3.8
%
51.5
52.8
0.21
34
36
(44790047)
29
25
13.08
28.81
3.9
1.6
—
—
—
0
0
(44806118)
29
25
13.08
28.81
3.9
1.6
—
—
—
0
0
(44790049)
29
25
13.08
28.81
3.9
1.6
—
—
—
0
0
(44790048)
29
25
13.08
28.81
3.9
1.6
—
—
—
0
0
(3000060) B lymphocytes [#/volume] in Blood
27
22
13.72
27.70
7.6
2.1
e6/l
155.8
393.6
1.31
19
14
(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood
27
22
13.72
27.70
7.6
1.9
%
34.6
24.3
2.13
27
22
(3006245) CD3-CD19+ cells/100 cells in Blood
27
25
12.06
25.57
7.6
2.7
%
5.7
16.0
1.88
27
25
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
32
38
9.58
25.50
4.6
1.8
—
—
—
0
0
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
43
76
6.69
24.34
1.6
1.6
—
—
—
0
0
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
47
94
5.99
23.46
20.0
4.3
%
87.1
92.7
0.83
47
94
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
27
6
50.51
22.90
1.2
1.0
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
43
81
6.26
22.80
1.5
1.6
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
26
5
58.08
22.59
1.5
2.0
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
142
684
3.68
21.63
35.2
7.0
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
40
76
6.13
20.96
1.9
1.6
u/ml
97.4
97.5
—
8
11
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
43
90
5.62
20.33
1.6
1.8
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
57
154
4.56
19.94
3.2
1.6
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
57
157
4.46
19.42
3.3
1.7
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
41
87
5.49
19.05
1.5
1.8
u/ml
114.7
165.3
1.12
28
46
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
64
197
4.08
18.76
13.9
4.3
umol/l
4.4
8.0
1.53
56
164
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
30
49
6.86
18.14
1.7
1.5
nmol/l
0.3
0.4
0.45
23
40
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
24
31
8.50
17.75
4.2
1.3
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
21
23
9.92
17.58
4.7
1.4
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
170
996
3.50
17.48
34.8
6.8
e9/l
0.5
0.6
3.52
161
865
(3006315) Basophils [#/volume] in Blood
170
999
3.48
17.33
34.8
6.8
e9/l
0.0
0.0
4.50
161
866
(3013115) Eosinophils [#/volume] in Blood
172
1021
3.50
17.18
39.9
7.5
e9/l
0.1
0.2
4.24
164
901
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
15
10
15.95
16.90
6.9
2.0
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
15
10
15.95
16.90
6.9
2.0
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
48
130
4.38
16.57
11.0
4.7
%
0.6
1.0
0.58
22
44
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
25
37
7.44
16.48
2.9
1.2
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
24
34
7.74
16.42
1.3
1.3
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
172
1040
3.38
16.26
35.1
6.8
e9/l
1.9
2.1
2.64
165
924
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
64
217
3.67
16.12
4.4
1.8
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
54
164
3.97
15.94
1.6
1.6
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
25
39
7.05
15.71
2.6
2.5
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
44
119
4.31
15.16
11.4
5.0
%
0.2
0.2
0.03
19
36
(3025159) Blasts/100 leukocytes in Blood
42
114
4.26
14.37
11.3
5.1
%
0.1
0.0
0.50
17
34
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
71
278
3.22
14.06
3.0
3.8
ng/l
623.2
1011.1
0.89
58
228
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
38
98
4.43
13.87
4.4
1.6
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
41
114
4.14
13.56
10.3
4.4
%
0.6
0.5
0.04
14
26
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
15
15
10.61
13.26
1.2
1.1
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
18
24
8.03
12.88
2.7
1.1
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
20
31
6.95
12.58
1.3
1.1
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
110
586
2.64
11.96
16.8
6.2
g/l
35.4
37.2
2.33
104
556
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
82
377
2.80
11.95
11.8
2.3
mg/l
1.8
1.0
1.16
67
275
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
20
34
6.33
11.53
8.7
8.5
u/ml
0.3
0.4
0.90
14
24
(3013650) Neutrophils [#/volume] in Blood by Automated count
168
1112
2.75
11.50
56.8
9.6
e9/l
2.9
3.9
10.96
159
966
(3023368) Bacteria identified in Blood by Culture
78
357
2.77
11.39
16.2
4.1
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
15
6
26.52
11.28
2.9
2.5
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
16
22
7.73
11.12
1.6
1.6
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
19
32
6.37
11.04
1.3
1.1
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
73
335
2.70
10.50
1.7
1.6
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
51
193
3.09
10.46
1.7
3.0
%
25.6
23.2
0.44
46
181
(3017446) Testosterone [Moles/volume] in Serum or Plasma
42
142
3.38
10.36
3.7
2.1
nmol/l
13.0
12.7
0.06
34
126
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
13
15
9.11
10.33
6.6
1.7
pg
33.9
32.7
0.43
13
15
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
129
780
2.43
10.26
27.7
8.6
mmol/l
1.2
1.2
0.38
111
690
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
21
43
5.26
9.99
2.3
1.2
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
21
43
5.26
9.99
2.3
1.2
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
12
13
9.67
9.95
19.4
1.9
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
53
211
2.95
9.91
2.1
1.7
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
120
713
2.38
9.80
27.1
8.5
mmol/l
1.2
1.2
0.26
115
662
(3013826) Glucose [Moles/volume] in Serum or Plasma
144
930
2.40
9.66
18.0
5.5
mmol/l
6.1
6.5
1.28
137
842
(3051611) Lipemic interference index of Serum or Plasma
12
14
8.98
9.43
19.8
1.9
—
—
—
0
0
(3020393) Adenovirus Ag [Presence] in Stool
13
17
8.03
9.37
2.8
2.0
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
53
224
2.76
8.81
3.5
2.3
nmol/l
339.1
378.7
0.85
53
213
(3021589) Normoblasts [#/volume] in Blood
142
935
2.29
8.79
46.6
9.3
e9/l
0.0
0.0
0.69
128
745
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
13
8
17.09
8.65
1.9
1.0
—
—
—
0
0
(3010503) CD19 cells [#/volume] in Blood
13
8
17.09
8.65
6.8
3.5
e9/l
0.3
0.1
—
13
8
(3033658) Prothrombin time (PT) actual/Normal
80
418
2.38
8.52
32.0
4.5
%
90.2
91.3
0.17
80
412
(42868452) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method
8
0
+∞
8.38
11.4
0.0
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
19
43
4.72
8.05
15.4
2.7
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
81
441
2.27
7.73
10.2
4.7
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
95
555
2.19
7.61
12.7
3.1
u/l
31.6
31.3
0.04
95
535
(3000093) Morphology [Interpretation] in Blood Narrative
12
19
6.60
7.31
1.1
1.3
—
—
—
0
0
(3016228) CD19 cells/100 cells in Blood
11
7
16.39
7.30
2.7
3.4
%
17.4
8.3
—
11
7
(21494814) CD8 cells/100 lymphocytes in Specimen
11
7
16.39
7.30
2.6
3.4
—
—
—
0
0
(40758558) Short blood count panel - Blood
88
508
2.16
7.19
61.2
7.1
—
—
—
0
0
(3018418) pH of Serum or Plasma
75
406
2.24
7.19
11.7
3.6
ph
7.4
7.4
0.01
17
63
(3032080) INR in Blood by Coagulation assay
86
492
2.17
7.19
6.0
7.2
inr
1.0
1.2
4.39
24
150
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
11
8
14.34
6.96
5.9
2.5
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
13
24
5.67
6.85
5.8
2.1
—
—
—
0
0
(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection
11
9
12.74
6.65
8.0
5.2
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
85
497
2.11
6.63
14.3
2.4
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
88
524
2.08
6.52
1.8
1.7
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
43
191
2.53
6.38
2.7
2.1
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
10
15
6.92
6.36
2.9
1.4
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
9
5
18.63
6.31
1.6
1.4
—
—
—
0
0
(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination
6
0
+∞
6.27
1.0
0.0
—
—
—
0
0
(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method
6
0
+∞
6.27
12.2
0.0
—
—
—
0
0
(43055187) t(12;21)(p13;q22.3)(ETV6,RUNX1) fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method
6
0
+∞
6.27
4.0
0.0
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
10
16
6.48
6.00
1.6
1.0
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
69
388
2.10
5.86
11.3
2.3
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
10
9
11.53
5.85
1.3
1.0
—
—
—
0
0
(4062490)
12
24
5.21
5.81
1.8
1.1
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
94
597
1.95
5.66
5.3
3.8
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
87
547
1.93
5.34
4.7
3.7
e6/l
41.9
52.7
0.16
74
426
(3000494) Fungus identified in Specimen by Culture
36
160
2.47
5.31
3.6
1.7
—
—
—
0
0
(4212803)
5
0
+∞
5.22
1.2
0.0
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
80
492
1.95
5.22
4.9
3.7
e6/l
0.1
0.2
0.26
67
374
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
11
23
4.97
5.06
1.4
1.1
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
22
78
3.01
4.97
2.3
1.1
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
78
487
1.90
4.81
5.0
3.7
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
40
196
2.25
4.74
1.6
1.5
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
12
29
4.31
4.68
1.2
1.6
—
—
—
0
0
(3000991) Gas panel - Venous blood
43
219
2.18
4.64
33.7
8.6
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
7
5
14.36
4.60
10.6
2.0
—
—
—
0
0
(4035726)
26
108
2.58
4.40
1.5
1.6
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
18
62
3.06
4.27
2.4
1.6
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
88
589
1.79
4.26
2.8
1.5
g/l
1.6
1.9
0.85
72
328
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
38
195
2.13
4.01
42.9
7.1
mmol/l
24.3
23.7
1.01
38
190
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
69
437
1.82
3.97
2.1
2.9
mg/l
2.5
2.8
0.64
61
379
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
12
33
3.78
3.97
1.6
1.6
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
10
24
4.31
3.93
1.1
1.5
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
93
649
1.71
3.81
5.6
4.5
e6/l
58.6
48.9
0.11
79
447
(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection
7
8
8.97
3.80
5.3
7.0
—
—
—
0
0
(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection
7
8
8.97
3.80
5.3
6.9
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
6
5
12.26
3.78
5.0
1.2
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
6
5
12.26
3.78
5.0
1.2
—
—
—
0
0
(3021387) Prolactin [Units/volume] in Serum or Plasma
28
130
2.31
3.75
1.9
1.6
mu/l
353.9
312.7
0.26
28
124
(3003396) Base excess in Arterial blood by calculation
27
124
2.33
3.71
12.2
12.5
mmol/l
0.7
0.0
0.38
18
99
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
8
12
6.85
3.70
12.9
4.6
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
15
51
3.07
3.64
1.5
1.8
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
44
248
1.95
3.60
38.3
6.7
mmol/l
1.9
1.5
0.59
39
185
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
7
9
7.97
3.58
1.4
1.0
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
20
81
2.60
3.57
1.5
1.3
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
13
41
3.30
3.55
1.3
1.1
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
8
13
6.33
3.53
2.5
1.6
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
14
47
3.10
3.47
1.5
1.0
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
13
42
3.22
3.42
2.0
1.9
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
16
60
2.79
3.30
1.3
2.3
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
6
7
8.75
3.28
10.2
1.4
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
6
7
8.75
3.28
10.2
1.4
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
6
7
8.75
3.28
10.2
1.4
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
182
1552
1.74
3.24
3.9
3.5
mmol/l
2.7
2.8
0.18
177
1447
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
8
16
5.13
3.07
1.6
1.5
—
—
—
0
0
(3007566) Smooth muscle Ab [Titer] in Serum
13
45
3.00
3.07
1.1
1.7
—
52.0
—
0
5
(3013727) Leukocytes other/100 leukocytes in Blood
6
8
7.66
3.07
20.3
6.0
%
51.8
55.7
—
6
8
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
7
12
5.97
3.04
1.4
1.9
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
104
782
1.59
3.02
13.8
4.0
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
29
150
2.06
3.01
1.8
1.4
u/ml
124.9
320.6
0.60
24
140
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
5
5
10.17
2.99
5.8
1.2
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
5
5
10.17
2.99
5.8
1.2
—
—
—
0
0
(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid
5
5
10.17
2.99
1.2
1.0
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
9
22
4.21
2.91
1.4
1.1
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
6
9
6.80
2.88
10.5
1.4
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
6
9
6.80
2.88
10.5
1.4
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
6
9
6.80
2.88
10.5
1.4
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
6
9
6.80
2.88
2.0
1.4
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
6
9
6.80
2.88
10.5
1.4
—
—
—
0
0
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
6
9
6.80
2.88
4.5
9.9
—
—
—
0
0
(3011648) Oxygen content in Venous blood
8
19
4.32
2.70
41.3
17.2
%
10.7
12.1
—
8
19
(3035933) Granulocytes/100 leukocytes in Blood
8
20
4.10
2.59
1.1
1.2
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
152
1741
0.65
2.56
3.9
3.8
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
6
11
5.56
2.56
1.2
1.0
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
10
33
3.12
2.56
33.4
11.8
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
20
96
2.18
2.51
2.4
2.3
ml/min/173m2
102.8
79.5
—
8
43
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
47
302
1.69
2.51
4.3
3.4
e6/l
0.7
0.7
0.04
29
177
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
7
16
4.47
2.49
9.9
1.6
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
7
16
4.47
2.49
9.9
1.6
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
7
16
4.47
2.49
9.9
1.6
—
—
—
0
0
(3022313) Gas panel - Capillary blood
31
178
1.85
2.41
6.8
6.8
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
5
8
6.35
2.38
1.2
1.4
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
7
17
4.21
2.38
1.0
1.0
—
—
—
0
0
(3031040) Bacteria [#/volume] in Urine by Automated count
138
1145
1.49
2.35
5.5
4.2
e6/l
83.7
24.5
—
7
18
(3019230) Fractional oxyhemoglobin in Venous blood
9
28
3.30
2.33
36.9
12.3
%
68.8
70.4
—
9
28
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
62
436
1.57
2.31
2.5
3.2
ng/l
18.6
30.2
0.90
40
236
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
6
13
4.70
2.28
2.0
3.9
ug/l
73.8
149.6
—
6
13
(3019060) Gas panel - Arterial blood
13
55
2.44
2.16
5.9
12.3
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
22
117
1.97
2.14
6.0
3.0
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
5
10
5.08
2.08
2.2
1.2
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
5
10
5.08
2.08
1.2
1.0
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
5
10
5.08
2.08
1.2
1.0
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
45
302
1.60
2.03
4.5
3.5
e6/l
2.7
2.9
0.07
26
177
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
9
32
2.88
2.02
5.1
1.3
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
171
1886
0.66
2.02
62.7
12.4
%
37.7
40.3
4.43
138
1585
(3034770) Mitochondria Ab [Titer] in Serum
12
51
2.43
1.98
1.0
1.6
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
5
139
0.35
1.96
1.2
1.3
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
39
564
0.63
1.88
2.1
2.5
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
18
94
1.99
1.86
6.3
4.0
mmol/l
1.2
1.2
0.37
18
83
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
33
210
1.66
1.83
7.5
6.6
mmol/l
1.6
1.0
0.92
26
152
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
37
245
1.60
1.77
3.3
3.5
ng/l
135.8
764.9
0.78
25
157
(3016038) Potassium [Moles/volume] in Urine
6
18
3.39
1.76
2.7
2.0
mmol/l
27.0
32.3
—
6
18
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
7
25
2.85
1.66
1.3
1.0
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
63
476
1.44
1.64
2.9
2.8
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
73
568
1.41
1.61
2.5
1.8
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
8
32
2.55
1.61
1.0
1.1
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
7
26
2.74
1.59
1.7
1.3
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
6
20
3.05
1.59
1.0
1.1
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
37
522
0.65
1.57
2.0
2.3
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
8
168
0.46
1.54
1.9
1.4
—
—
—
0
0
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
5
15
3.38
1.53
1.0
1.0
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
188
1721
1.45
1.50
62.6
14.1
%
13.7
13.3
4.14
188
1690
(40761535) Cells panel - Urine sediment
18
103
1.81
1.45
5.2
3.0
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
5
16
3.17
1.44
1.4
1.2
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
162
1451
1.37
1.43
23.0
9.0
ml/min/173m2
100.7
96.7
1.28
144
1092
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
12
60
2.05
1.40
22.6
20.3
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
7
29
2.46
1.40
1.0
1.1
—
—
—
0
0
(3003338) MCHC [Mass/volume]
164
1788
0.73
1.38
69.9
13.9
g/l
336.9
334.6
2.64
164
1775
(3025468) Yersinia sp identified in Specimen by Organism specific culture
5
17
2.98
1.36
8.4
1.4
—
—
—
0
0
(3020717) Zinc [Moles/volume] in Serum or Plasma
5
17
2.98
1.36
3.6
1.9
umol/l
10.5
16.9
—
5
17
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
204
1907
1.50
1.35
36.0
8.1
u/l
35.3
26.5
4.57
204
1847
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
85
697
1.34
1.34
2.2
1.8
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
77
625
1.34
1.29
2.4
1.6
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
5
18
2.81
1.29
8.4
1.3
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
5
18
2.81
1.29
8.4
1.3
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
5
18
2.81
1.29
8.4
1.3
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
5
18
2.81
1.29
8.4
1.3
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
5
18
2.81
1.29
8.4
1.3
—
—
—
0
0
(4027681)
5
19
2.67
1.22
1.2
1.1
—
—
—
0
0
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
27
183
1.54
1.20
8.5
6.8
mmol/l
24.9
24.3
1.06
27
178
(3000963) Hemoglobin [Mass/volume] in Blood
208
2170
0.66
1.19
68.1
16.2
g/l
128.9
136.0
6.68
208
2142
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
11
196
0.54
1.19
1.5
1.4
—
—
—
0
0
(4268621)
5
20
2.53
1.15
2.4
2.3
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
15
242
0.59
1.14
1.2
1.3
—
—
—
0
0
(3035941) MCH [Entitic mass]
208
2167
0.67
1.12
67.6
16.0
pg
30.0
29.7
1.36
208
2140
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
14
81
1.77
1.11
1.1
1.5
—
—
—
0
0
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
8
41
1.98
1.10
1.3
1.5
—
—
—
0
0
(3024731) MCV [Entitic volume]
208
2166
0.68
1.09
67.6
16.0
fl
89.3
88.6
1.03
208
2140
(3043409) Potassium [Moles/volume] in Arterial blood
7
33
2.15
1.06
5.6
3.0
mmol/l
3.6
3.8
—
7
28
(3013512) EKG study
43
329
1.38
1.04
3.1
3.4
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
5
22
2.30
1.04
1.2
1.6
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
7
34
2.09
1.03
1.1
1.9
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
7
34
2.09
1.03
1.0
1.1
—
—
—
0
0
(40765089) Chromosome analysis panel - Blood by G-banded
5
23
2.20
0.98
1.0
1.0
—
—
—
0
0
(3014007) Fractional oxyhemoglobin in Arterial blood
13
77
1.73
0.97
20.5
10.8
%
95.2
94.4
0.40
13
77
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
13
78
1.71
0.93
20.5
10.6
%
0.8
0.7
0.48
13
78
(4306422)
6
28
2.17
0.92
1.0
1.2
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
6
28
2.17
0.92
1.2
1.1
—
—
—
0
0
(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood
13
79
1.68
0.90
20.5
10.5
%
1.6
1.4
0.20
13
79
(3044889) 12 lead EKG panel
110
973
1.24
0.90
3.6
2.8
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
6
29
2.10
0.90
1.0
1.1
—
—
—
0
0
(3047181) Lactate [Moles/volume] in Blood
6
30
2.03
0.87
7.7
20.7
mmol/l
1.5
1.1
—
6
23
(3029937) Albumin [Presence] in Urine by Test strip
56
459
1.29
0.86
3.5
3.5
estimate
0.0
0.0
0.50
17
171
(3000475) Leukocytes [#/volume] in Synovial fluid
0
25
0.00
0.79
0.0
1.4
—
18371.8
—
0
17
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
0
26
0.00
0.79
0.0
22.2
—
1162.7
—
0
26
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
60
504
1.26
0.76
2.0
1.7
pmol/l
104.0
95.6
0.51
34
261
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
5
24
2.11
0.75
1.2
1.7
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
15
217
0.67
0.74
1.3
1.9
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
50
414
1.26
0.72
3.2
3.1
kg/l
1.0
1.0
—
7
62
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
21
283
0.72
0.72
1.1
1.3
u/ml
1.1
6.9
—
8
107
(46235355) HIV 1 and 2 tests - Meaningful Use set
78
680
1.22
0.70
1.9
2.1
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
99
885
1.20
0.69
3.9
3.5
estimate
0.0
0.0
0.00
18
167
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
17
119
1.46
0.69
1.1
1.4
miu/ml
361.6
290.1
—
5
65
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
5
92
0.53
0.68
2.8
1.5
—
—
—
0
0
(4094501)
5
28
1.80
0.66
1.0
1.1
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
49
409
1.25
0.66
3.9
3.5
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
98
879
1.20
0.65
5.6
5.0
estimate
0.0
0.0
0.00
18
174
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
14
199
0.68
0.65
4.2
3.9
%
19.3
20.8
—
5
88
(4010399)
15
104
1.47
0.64
1.1
1.4
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
6
103
0.57
0.63
2.5
1.7
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
53
450
1.23
0.62
2.2
1.6
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
8
51
1.59
0.61
1.1
1.2
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
0
20
0.00
0.60
0.0
1.5
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
18
241
0.73
0.60
1.7
1.5
—
—
—
0
0
(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum
0
21
0.00
0.60
0.0
1.4
—
4.9
—
0
15
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
7
114
0.60
0.59
1.9
2.0
—
—
—
0
0
(3000492) Spirometry study
13
184
0.69
0.59
1.6
1.3
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
32
257
1.28
0.59
1.5
1.6
pmol/l
388.7
449.1
0.45
26
231
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
0
23
0.00
0.58
0.0
1.1
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
97
877
1.18
0.58
3.6
3.4
estimate
0.0
0.0
0.00
16
171
(3021901) Oxygen saturation in Capillary blood
6
35
1.73
0.58
2.8
2.3
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
8
54
1.50
0.58
1.1
1.1
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
11
160
0.67
0.58
1.7
2.5
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
158
1493
1.17
0.53
4.6
3.2
mmol/l
5.6
5.7
0.11
153
1363
(3020961) Endomysium IgA Ab [Titer] in Serum
21
163
1.32
0.50
1.1
1.2
—
16.2
—
0
5
(3020891) Body temperature
7
45
1.57
0.49
5.9
4.8
—
—
—
0
0
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
7
46
1.54
0.48
6.1
16.0
%
1.5
1.5
—
7
41
(3018405) Lactate [Moles/volume] in Arterial blood
7
46
1.54
0.48
5.6
4.6
mmol/l
1.1
1.5
—
7
46
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
7
48
1.47
0.47
1.6
1.5
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
8
118
0.67
0.47
1.9
1.7
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
11
151
0.72
0.44
1.8
1.2
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
51
577
0.85
0.43
3.0
2.2
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
5
33
1.53
0.41
1.0
1.1
—
—
—
0
0
(4146454)
0
16
0.00
0.41
0.0
3.2
—
—
—
0
0
(3018738) Hemoglobin F/Hemoglobin.total in Blood
0
16
0.00
0.41
0.0
3.6
—
2.9
—
0
8
(3044941) Cell count panel - Synovial fluid
0
16
0.00
0.41
0.0
1.2
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
0
17
0.00
0.41
0.0
1.2
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
73
663
1.15
0.40
3.7
3.3
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
14
106
1.34
0.40
1.6
1.2
—
—
—
0
0
(3041806) Other cells [#/volume] in Blood by Manual count
0
19
0.00
0.39
0.0
1.7
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
9
67
1.36
0.38
2.2
3.3
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
129
1220
1.13
0.37
5.7
4.3
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
17
135
1.28
0.36
12.9
6.0
—
—
—
0
0
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
6
41
1.48
0.36
1.5
1.8
nmol/l
1.5
0.6
—
6
35
(3019225) pH of Specimen
14
108
1.31
0.36
17.9
4.3
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
15
189
0.78
0.36
1.5
2.0
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
19
232
0.80
0.35
1.4
1.9
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
19
230
0.81
0.33
1.4
1.9
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
19
229
0.81
0.32
1.4
1.9
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
14
175
0.79
0.32
1.4
2.0
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
7
100
0.69
0.31
1.1
1.7
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
19
228
0.82
0.31
1.4
1.9
—
—
—
0
0
(3002256) Pathology report gross observation
19
157
1.23
0.30
1.6
1.2
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
194
1891
1.14
0.30
46.6
11.1
mg/l
18.3
21.7
1.03
170
1388
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
7
55
1.28
0.30
1.1
1.9
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
7
55
1.28
0.30
1.3
1.7
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
9
117
0.76
0.28
1.4
1.4
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
9
117
0.76
0.28
1.4
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
9
117
0.76
0.28
1.4
1.4
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
9
117
0.76
0.28
1.4
1.4
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
15
181
0.82
0.26
1.1
1.0
—
—
—
0
0
(1616796) Gas panel - Central venous blood
5
38
1.32
0.23
1.2
3.8
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
5
39
1.29
0.23
1.2
1.1
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
5
41
1.22
0.22
2.2
4.1
—
—
—
0
0
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
2.6
—
80.4
—
0
11
(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(3010144) Erythrocytes [#/volume] in Synovial fluid
0
11
0.00
0.21
0.0
1.0
—
17265.6
—
0
5
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
0
10
0.00
0.21
0.0
3.9
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
0
10
0.00
0.21
0.0
3.0
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
0
12
0.00
0.21
0.0
7.1
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
0
13
0.00
0.21
0.0
1.3
—
—
—
0
0
(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(3042299) inFLIXimab [Mass/volume] in Serum or Plasma
0
13
0.00
0.21
0.0
9.3
—
10.7
—
0
13
(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
(3015235) Bicarbonate [Moles/volume] in Capillary blood
6
48
1.26
0.20
5.2
3.4
mmol/l
23.6
23.7
—
6
42
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
0
14
0.00
0.20
0.0
1.4
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
0
14
0.00
0.20
0.0
2.6
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
6
49
1.23
0.20
14.3
2.2
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
6
50
1.21
0.20
1.3
1.2
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
6
50
1.21
0.20
2.0
1.6
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
6
53
1.14
0.19
1.2
1.1
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
30
330
0.90
0.18
2.0
2.0
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
7
59
1.19
0.18
1.1
1.2
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
7
60
1.17
0.18
1.3
1.1
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
7
60
1.17
0.18
1.3
1.1
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
5
66
0.75
0.17
2.4
1.1
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
20
177
1.14
0.17
2.3
2.4
u/l
24779.8
4344.7
—
6
72
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
11
129
0.85
0.15
1.5
1.5
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
9
83
1.09
0.15
1.1
1.4
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
20
179
1.13
0.14
1.2
1.2
iu/ml
182.8
133.9
0.31
12
69
(3043238) Trisomy 21 risk [Likelihood] in Fetus
8
98
0.81
0.14
1.6
1.5
—
—
—
0
0
(3022145) Colonoscopy Study observation
17
151
1.14
0.13
1.1
1.4
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
18
161
1.13
0.13
3.0
3.6
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
10
116
0.86
0.12
1.2
1.2
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
53
506
1.06
0.11
3.4
3.0
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
5
45
1.11
0.10
1.0
1.1
—
13.8
—
0
7
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
30
282
1.07
0.09
1.1
1.3
iu/ml
10.0
29.5
—
6
83
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
6
55
1.09
0.09
1.0
1.4
—
—
—
0
0
(40768443) Skin Pathology biopsy report
6
55
1.09
0.09
1.0
1.2
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
5
63
0.79
0.08
2.4
1.0
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
5
65
0.76
0.08
2.4
1.0
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
195
1968
0.95
0.08
24.0
9.8
—
—
—
0
0
(3022621) pH of Urine by Test strip
11
98
1.13
0.08
4.6
2.1
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
20
186
1.08
0.07
1.2
1.3
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
12
132
0.90
0.07
2.6
1.8
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
8
95
0.84
0.07
1.5
1.5
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
8
95
0.84
0.07
1.5
1.5
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
30
312
0.96
0.04
3.7
4.1
mg/mmol
6.3
14.4
1.19
24
210
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
66
647
1.03
0.04
1.4
1.6
u/ml
0.7
2.1
1.82
19
136
(3003327) Ova and parasites identified in Stool by Light microscopy
11
102
1.08
0.03
1.6
1.6
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
10
93
1.08
0.02
1.3
1.2
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
33
322
1.03
0.02
1.8
1.5
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
10
106
0.94
0.01
1.5
2.3
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
46
456
1.01
0.00
1.6
1.8
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
26
259
1.00
0.00
1.2
1.2
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
27
269
1.00
0.00
1.6
1.9
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
36
362
0.99
0.00
1.9
3.0
ug/g
83.3
99.1
0.26
28
279
(3005011) Chlamydia sp Ab [Titer] in Serum
0
9
0.00
0.00
0.0
1.6
—
—
—
0
0
(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3034988) Calcium [Moles/volume] in Capillary blood
0
9
0.00
0.00
0.0
3.1
—
1.2
—
0
9
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
6
67
0.89
0.00
1.0
1.1
—
16.8
—
0
7
(3045716) Anion gap in Serum or Plasma
0
8
0.00
0.00
0.0
2.9
—
9.6
—
0
8
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3032868) Hemoglobin electrophoresis panel in Blood
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
7
71
0.99
0.00
1.9
2.2
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
0
5
0.00
0.00
0.0
16.0
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
0
5
0.00
0.00
0.0
7.2
—
—
—
0
0
(4034850)
5
58
0.86
0.00
9.2
9.7
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
9
97
0.93
0.00
1.2
1.1
—
—
—
0
0
(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3006576) Bicarbonate [Moles/volume] in Blood
0
5
0.00
0.00
0.0
9.8
—
24.3
—
0
5
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(1002224) Polysomnography panel
7
77
0.91
0.00
1.0
1.1
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(4211845)
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
6
59
1.02
0.00
1.0
1.8
u/l
49.3
42.0
—
6
53
(3012565) Volume of 24 hour Urine
0
8
0.00
0.00
0.0
1.4
—
2175.0
—
0
8
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
5
50
1.00
0.00
5.0
2.0
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
30
300
1.00
0.00
2.9
3.3
mg/l
1696.8
96.3
0.46
25
206
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3010838) Calcium [Moles/time] in 24 hour Urine
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3004446) Plasmodium sp identified in Blood by Light microscopy
0
5
0.00
0.00
0.0
3.4
—
—
—
0
0
(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood
0
7
0.00
0.00
0.0
4.7
—
1.2
—
0
7
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
0
8
0.00
0.00
0.0
6.3
—
—
—
0
0
(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction
0
5
0.00
0.00
0.0
1.2
—
197.2
—
0
5
(3044927) Protein electrophoresis panel - Urine
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(21494262) English walnut recombinant (rJug r) 3 IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
21.2
—
0
5
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3038071) Oxygen [Partial pressure] in Mixed venous blood
0
8
0.00
0.00
0.0
6.3
—
—
—
0
0
(3011048) Pyruvate [Moles/volume] in Blood
0
6
0.00
0.00
0.0
1.5
—
87.5
—
0
6
(3001820) Epstein Barr virus nuclear Ab [Presence] in Serum
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
9
95
0.95
0.00
2.0
1.3
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: C3_ALL – Acute lymphocytic leukaemia
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).